Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea. [PDF]
Ther Adv HematolKim DH +8 more
europepmc +1 more source
CAR-T therapy: Trailblazing CAR(ing) in cancer treatment. [PDF]
OncotargetSaqib U, Pandey M, Hajela K.
europepmc +1 more source
The role of 67 kDa laminin receptor in G-CSF-induced hematopoietic stem cell mobilization [PDF]
, 2007 Visconte, Valeria
core +1 more source
Understanding the Role and Clinical Management of Bridging Therapy During CAR T-Cell Therapy for Relapsed or Refractory Multiple Myeloma. [PDF]
J Adv Pract OncolHwa YL +4 more
europepmc +1 more source
A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation. [PDF]
Cell TransplantMorandi F +8 more
europepmc +1 more source
Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer [PDF]
, 2014 core +1 more source
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing. [PDF]
Cancer Rep (Hoboken)Hirano T +10 more
europepmc +1 more source
Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma. [PDF]
J Clin ApherPassos RMA +6 more
europepmc +1 more source
Rare but rising: oncologic emergencies in the neonatal ICU. [PDF]
Ann Med Surg (Lond)Ali MR, Talpur A, Irshad NUN, Imran SB.
europepmc +1 more source